These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci]. Oğuz VA, Yapar N, Sezak N, Cavuş SA, Kurutepe S, Peksel H, Cakir N, Yüce A. Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378 [Abstract] [Full Text] [Related]
6. [In vitro study of the cefamandole-fosfomycin combination against methicillin-resistant staphylococci]. Fosse T, David MF, Duluc F, Darmusey D, Tamalet C, Toga B. Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):528-31. PubMed ID: 6462742 [Abstract] [Full Text] [Related]
8. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin. Graninger W, Leitha T, Breyer S, Francesconi M, Lenz K, Georgopoulos A. Drugs Exp Clin Res; 1985 Jun; 11(1):23-7. PubMed ID: 3869801 [Abstract] [Full Text] [Related]
9. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics. Samra Z, Ofer O, Shmuely H. Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257 [Abstract] [Full Text] [Related]
10. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients. Kratzer C, Rabitsch W, Hirschl AM, Graninger W, Presterl E. Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506 [Abstract] [Full Text] [Related]
11. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model. Hamel A, Caillon J, Jacqueline C, Batard E, Potel G. Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281 [Abstract] [Full Text] [Related]
12. [Antibiotic sensitivity tests of methicillin-resistant staphylococci]. Sultan N, Türet S, Imir T. Mikrobiyol Bul; 1991 Jul; 25(3):227-34. PubMed ID: 1762589 [Abstract] [Full Text] [Related]
15. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method. Quentin C, Saivin S, Lafferriere C, Noury P, Bebear C. Drugs Exp Clin Res; 1987 Jul; 13(4):219-24. PubMed ID: 3476291 [Abstract] [Full Text] [Related]
16. [Are we being threatened by multiresistant strains of Staphylococcus aureus?]. Aepfelbacher M. MMW Fortschr Med; 2005 Jan 27; 147(4):33-5, 37. PubMed ID: 15745339 [Abstract] [Full Text] [Related]
17. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). Sader HS, Watters AA, Fritsche TR, Jones RN. BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104 [Abstract] [Full Text] [Related]
19. In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus. Sahuquillo Arce JM, Colombo Gainza E, Gil Brusola A, Ortiz Estévez R, Cantón E, Gobernado M. Rev Esp Quimioter; 2006 Sep 18; 19(3):252-7. PubMed ID: 17099793 [Abstract] [Full Text] [Related]
20. [Resistance to streptogramin antibiotics in "Staphylococcus aureus" (author's transl)]. Dublanchet A, Soussy CJ, Squinazi F, Duval J. Ann Microbiol (Paris); 1977 Apr 18; 128A(3):277-87. PubMed ID: 411409 [Abstract] [Full Text] [Related] Page: [Next] [New Search]